THC: Tenet Healthcare Corporation Stock

by  •  • Comments Off on THC: Tenet Healthcare Corporation Stock

SIC 8062 – General Medical and Surgical Hospitals

Valuation
Market Cap ($M) 15,494.15
Enterprise Value ($M) 28,512.15
Book Value ($M) 8,075.00
Book Value / Share 84.91
Price / Book 1.92
NCAV ($M) -12,538.00
NCAV / Share -131.84
Price / NCAV -1.24

Profitability (mra)
Return on Invested Capital (ROIC) 0.15
Return on Assets (ROA) 0.11
Return on Equity (ROE) 0.60

Liquidity (mrq)
Quick Ratio 1.52
Current Ratio 1.58

Balance Sheet (mrq) ($M)
Current Assets 8,759.00
Assets 29,372.00
Liabilities 21,297.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
1 day ago 13G/A Price T Rowe Associates Inc /md/ 7.80 4.72
1 day ago 13G/A Glenview Capital Management, Llc 2.77 -65.66
3 days ago 13G Fmr Llc 8.04 70.58
02-15 13G Lind Global Fund II LP 9.90
02-14 13G/A Harris Associates L P 0.00 -99.93
02-13 13G/A Vanguard Group Inc 10.94 -1.71
02-09 13G Invesco Ltd. 5.30 29.82
02-02 13G/A BlackRock Inc. 10.70 -5.36

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-10-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2024 OR ¨ Transition report pursuan
2024-07-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2024 OR ¨ Transition report pursuant to
2024-04-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2024 OR ¨ Transition report pursuant to
2024-02-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ý Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2023 OR ¨ Transition report pursuant to Sect

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-14 429,407 1,757,855 24.43
2024-11-13 141,756 740,560 19.14
2024-11-12 154,352 789,670 19.55
2024-11-11 154,645 759,706 20.36

(click for more detail)

Similar Companies
HCA – HCA Healthcare, Inc. MD – Pediatrix Medical Group, Inc.
SEM – Select Medical Holdings Corporation


Financial data and stock pages provided by
Fintel.io